N
Nisha Ohri
Researcher at Rutgers University
Publications - 55
Citations - 610
Nisha Ohri is an academic researcher from Rutgers University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 10, co-authored 40 publications receiving 447 citations. Previous affiliations of Nisha Ohri include Icahn School of Medicine at Mount Sinai & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
Remy Lim,Anne Eaton,Nancy Y. Lee,Jeremy Setton,Nisha Ohri,Shyam Rao,Richard J. Wong,Matthew G. Fury,Heiko Schöder +8 more
TL;DR: Parameter capturing the volume of 18F-FDG–positive disease (MTV or TLG) provide important prognostic information in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy and should be considered for risk stratification in this disease.
Journal ArticleDOI
Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database
Parul Agarwal,Erin Moshier,Meng Ru,Nisha Ohri,Ronald D. Ennis,Kenneth E. Rosenzweig,Madhu Mazumdar +6 more
TL;DR: Simulation studies showing ways to reduce the effect of ITB indicate that TD exposures should be included as variables in hazard-based analyses, and estimates of TD models were closest to the true treatment effect.
Journal ArticleDOI
Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis.
Nisha Ohri,Peter G. Cordeiro,Jennifer Keam,Åse Ballangrud,Weiji Shi,Zhigang Zhang,Claire T. Nerbun,Katherine M. Woch,Nicholas F. Stein,Ying Zhou,Beryl McCormick,Simon N. Powell,Alice Y. Ho +12 more
TL;DR: Implant reconstruction does not compromise the technical quality of PMRT when the IMNs are untreated, and treatment technique, not reconstruction, is the primary determinant of target coverage and normal tissue doses.
Journal ArticleDOI
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
Maaike van Gerwen,Naomi Alpert,Andrea S. Wolf,Nisha Ohri,Erik Lewis,Kenneth E. Rosenzweig,Raja M. Flores,Emanuela Taioli +7 more
TL;DR: Findings may lead to exploring new therapeutic options, such as targeting estrogen receptor beta, and considering hormonal therapy including estrogens for patients with otherwise limited prognosis, as well as exploring the effect of age and histology, two known independent factors affecting survival.
Journal ArticleDOI
Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer
Anuj Goenka,Luc G. T. Morris,Shyam Rao,Suzanne L. Wolden,Richard J. Wong,Dennis H. Kraus,Nisha Ohri,Jeremy Setton,Benjamin H. Lok,Nadeem Riaz,Borys Mychalczak,Heiko Schöder,Ian Ganly,Jatin P. Shah,David G. Pfister,Michael J. Zelefsky,Nancy Y. Lee +16 more
TL;DR: This is the first comprehensive analysis of a large, uniform cohort of N+ OPSCC patients achieving a PET/CT‐based complete response (CR) after chemoradiotherapy, and undergoing observation, rather than ND.